These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8199315)
1. Mechanism of aralkyl-DNA adduct formation from benzo[a]pyrene in vivo. Stansbury KH; Flesher JW; Gupta RC Chem Res Toxicol; 1994; 7(2):254-9. PubMed ID: 8199315 [TBL] [Abstract][Full Text] [Related]
2. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269 [TBL] [Abstract][Full Text] [Related]
3. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts. Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471 [TBL] [Abstract][Full Text] [Related]
4. Formation and persistence of benzo[a]pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformation. Suh M; Ariese F; Small GJ; Jankowiak R; Hewer A; Phillips DH Carcinogenesis; 1995 Oct; 16(10):2561-9. PubMed ID: 7586167 [TBL] [Abstract][Full Text] [Related]
5. Formation of benzylic-DNA adducts resulting from 7,12-dimethylbenz[a]anthracene in vivo. Ravi Kumar MN; Vadhanam MV; Horn J; Flesher JW; Gupta RC Chem Res Toxicol; 2005 Apr; 18(4):686-91. PubMed ID: 15833028 [TBL] [Abstract][Full Text] [Related]
6. Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene. Arif JM; Smith WA; Gupta RC Mutat Res; 1997 Aug; 378(1-2):31-9. PubMed ID: 9288883 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene. Godschalk RW; Vermeer IT; Kriek E; Floot B; Schilderman PA; Moonen EJ; Kleinjans JC; van Schooten FJ Chem Biol Interact; 1997 Apr; 104(1):41-54. PubMed ID: 9158694 [TBL] [Abstract][Full Text] [Related]
8. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents. Smith WA; Gupta RC Carcinogenesis; 1996 Jun; 17(6):1285-90. PubMed ID: 8681444 [TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro. Surh YJ; Liem A; Miller EC; Miller JA Carcinogenesis; 1989 Aug; 10(8):1519-28. PubMed ID: 2752526 [TBL] [Abstract][Full Text] [Related]
10. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide. Ginsberg GL; Atherholt TB Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163 [TBL] [Abstract][Full Text] [Related]
11. Formation and persistence of DNA adducts in the liver of brown bullheads exposed to benzo[a]pyrene. Sikka HC; Rutkowski JP; Kandaswami C; Kumar S; Earley K; Gupta RC Cancer Lett; 1990 Jan; 49(1):81-7. PubMed ID: 2105836 [TBL] [Abstract][Full Text] [Related]
12. Effects of solvent on DNA adduct formation in skin and lung of CD1 mice exposed cutaneously to benzo(a)pyrene. Booth ED; Loose RW; Watson WP Arch Toxicol; 1999 Aug; 73(6):316-22. PubMed ID: 10447559 [TBL] [Abstract][Full Text] [Related]
13. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner. Perlow RA; Kolbanovskii A; Hingerty BE; Geacintov NE; Broyde S; Scicchitano DA J Mol Biol; 2002 Aug; 321(1):29-47. PubMed ID: 12139931 [TBL] [Abstract][Full Text] [Related]
14. Comparative 32P-postlabeling analysis of benzo[a]pyrene--DNA adducts formed in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes. Roggeband R; Wolterbeek AP; Rutten AA; Baan RA Carcinogenesis; 1993 Sep; 14(9):1945-50. PubMed ID: 8403223 [TBL] [Abstract][Full Text] [Related]
15. Interception of reactive, DNA adduct-forming metabolites present in rodent serum following carcinogen exposure: implications for use of body fluids in biomonitoring. Garg A; Beach AC; Gupta RC Teratog Carcinog Mutagen; 1993; 13(4):151-66. PubMed ID: 7903484 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts. Nesnow S; Davis C; Nelson G; Ross JA; Allison J; Adams L; King LC Carcinogenesis; 1997 Oct; 18(10):1973-8. PubMed ID: 9364008 [TBL] [Abstract][Full Text] [Related]
17. Benzo(a)pyrene:DNA adduct formation in early-passage Wistar rat embryo cell cultures: evidence for multiple pathways of activation of benzo(a)pyrene. Pruess-Schwartz D; Baird WM Cancer Res; 1986 Feb; 46(2):545-52. PubMed ID: 3940629 [TBL] [Abstract][Full Text] [Related]
18. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by aryl hydrocarbon hydroxylase inducers. Wilson AG; Kung HC; Boroujerd M; Anderson MW Cancer Res; 1981 Sep; 41(9 Pt 1):3453-60. PubMed ID: 6266656 [TBL] [Abstract][Full Text] [Related]
19. DNA damage induced in mouse tissues by organic wood preserving waste extracts as assayed by 32P-postlabeling. Randerath E; Zhou GD; Donnelly KC; Safe SH; Randerath K Arch Toxicol; 1996; 70(11):683-95. PubMed ID: 8896714 [TBL] [Abstract][Full Text] [Related]
20. 32P-postlabeling analysis of the DNA adducts of 6-fluorobenzo[a]pyrene and 6-methylbenzo[a]pyrene formed in vitro. Todorovic R; Devanesan PD; Rogan EG; Cavalieri EL Chem Res Toxicol; 1993; 6(4):530-4. PubMed ID: 8374053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]